Barinthus Biotherapeutics News

3: Initial statement of beneficial ownership of securities-Officer Lynn Geoffrey

16:10 ET

8-K: Current report

Nov 25 16:08 ET

8-K: Current report

Nov 15 11:08 ET

10-Q: Q3 2024 Earnings Report

Nov 6 08:12 ET

8-K: Barinthus Bio Reports Third Quarter 2024 Update on Corporate Developments and Financial Results

Nov 6 08:07 ET

SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)

Nov 1 11:22 ET

SC 13G: Statement of acquisition of beneficial ownership by individuals-Frank W. Cawood(5.9%)

Oct 15 11:09 ET

8-K: Current report

Sep 5 16:13 ET

10-Q: Q2 2024 Earnings Report

Aug 8 08:14 ET

8-K: Barinthus Bio Reports Second Quarter 2024 Update on Corporate Developments and Financial Results

Aug 8 08:09 ET

4: Statement of changes in beneficial ownership of securities-Officer Hooftman Leon

Jun 18 16:13 ET

3: Initial statement of beneficial ownership of securities-Officer Hooftman Leon

Jun 18 16:09 ET

8-K: Current report

Jun 12 16:15 ET

8-K: Current report

Jun 6 16:07 ET

Barinthus Biotherapeutics | 8-K: Current report

May 15 16:17 ET

Barinthus Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director Wright Robin

May 14 16:29 ET

Barinthus Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director DAWES KAREN A

May 14 16:29 ET

Barinthus Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director Scheeren Joseph

May 14 16:28 ET

Barinthus Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director Phillips Anne M.

May 14 16:25 ET

Barinthus Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director Hammacher Alex

May 14 16:24 ET